Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
FDA
Congress Seeks Information from FDA on Powerful Opioid
Drug pricing and opioids have remained front and center as the 116th Congress got sworn in and started hosting hearings and…
Ned Sharpless Appointed Acting FDA Commissioner
Scott Gottlieb, MD, Commissioner of the United States Food and Drug Administration (FDA), announced his resignation from his post…
21st Century Cures Act: Implementation Update
The Office of the National Coordinator for Health IT (ONC) has come under fire for what some consider a slow implementation of the…
Need a Prescription? There May Be an App for That…Soon
Smartphones have become ubiquitous today. Need a cab? There’s an app (or several) for that. Need to order groceries to be…
FDA Releases Two Draft Guidances on REMS Programs
On January 24, 2019, the United States Food and Drug Administration (FDA) released two draft guidances focused on improving the…
CDER Priorities for 2019
Recently, the U.S. Food and Drug Administration’s (FDA) director of the Center for Drug Evaluation and Research (CDER) described…
FDA Considers 2018 Banner Year for Drug Development
For over two decades, 1996 has stood out as a successful year for drug approvals, with a whopping 53 approvals following a new…
Merck Case Makes it to SCOTUS, Focuses on Who Has Final Say in Warning…
On January 7, 2019, the Supreme Court of the United States (SCOTUS) heard oral arguments about who has the final say in warnings…
CDRH Proposed 510(k) Program Expansion Yields Mixed Reactions
In September 2018, the United States Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH)…
FDA Proposes Changes to Institutional Review Boards
The US Food and Drug Administration (FDA) recently proposed changes that would allow institutional review boards (IRBs) to waive…